Bills › 89th General Assembly
Relating to controlled substances, including amending the controlled substance schedules and information collection and reporting requirements under the Iowa prescription monitoring program, and including effective date provisions
Sponsored by the House Human Resources Committee
Topics:State governmentHealth care
Where it is now
- Done: IntroducedJanuary 18, 2022
- Done: SubcommitteeJanuary 18, 2022
- Done: House committeeJanuary 27, 2022
- Done: Passes the HouseFebruary 22, 202294–1
- Done: Senate committeeMarch 17, 2022
- Done: Passes the SenateApril 12, 202248–0
- Done: To the GovernorMay 2, 2022
- Done: Signed into lawMay 2, 2022
Signed into law What’s a funnel?
What’s in it
AI summary This law updates the list of controlled substances in Iowa to match federal chemical names. It also changes how the advisory council for the state's prescription monitoring program is chosen and organized. The council will now be appointed by a board instead of the governor and will have new responsibilities to protect patient privacy and civil liberties.1
Read the official explanation
This bill relates to controlled substances, including amending the controlled substance schedules and information collection and reporting requirements under the Iowa prescription monitoring program, and including effective date provisions. DIVISION I —— CONTROLLED SUBSTANCE SCHEDULES —— PRECURSOR SUBSTANCES REPORTING.), parts 1300, 1308, and 1310. The division takes effect upon enactment. DIVISION II —— IOWA PRESCRIPTION MONITORING PROGRAM. This division amends the composition and appointment of the Iowa prescription monitoring program advisory council. The bill changes the advisory council from a governor-appointed council to a board-appointed council; removes the minimum number of council members; modifies the composition of the council; directs the board to adopt rules on matters pertaining to council membership including terms of appointment and quorum; requires the board to consult with professional organizations and licensing boards for counsel membership; and expands the responsibility of the council to monitor and ensure that patient confidentiality, best interests, and civil liberties are at all times protected and preserved during the existence of the prescription monitoring program.
House subcommittee
Named January 18, 2022 (as HSB 549). On January 20, 2022 it recommended amendment and passage. Vote Total: 3-0.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Iowa Code it changes
Lobbying
4 for · 0 against · 16 undecided · Who →
Family tree
Study bill
89th General Assembly